CEO: | Sean M. Smith |
CFO: | Alexander John Abrey |
Non-Executive Chairman: | Lykele van der Broek |
Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
Website: | http://www.edenresearch.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB0001646941 |
Currency | UK Pounds |
Share Price | 3.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 4.50 |
52 Week Low | 2.35 |
Volume | 0 |
Shares Issued | 533.35m |
Market Cap | £20.00m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research